Prepare for your visit
Timothy Thien Tran
Family Medicine · Riverside, CA · NPI 1336460914
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$14,823.19
in general payments reported to CMS, 2019-2025 · $1,664 in 2025
The $1,664 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Who reported paying
General payments only, top 6 by amount.
- Astrazeneca Pharmaceuticals LP $3,351.46
- Abbvie INC. $1,480.02
- Boehringer Ingelheim Pharmaceuticals, INC. $1,204.72
- Amgen INC. $1,050.36
- Nestle Healthcare Nutrition INC. $1,003.40
- Novo Nordisk INC $981.33
Drugs and devices associated with these payments
Jardiance Zenpep Farxiga Airsupra Dupixent Linzess Repatha Otezla Breztri Evenity Ozempic Rybelsus
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Timothy Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1310697/timothy-thien-tran